Efficacy and safety of trabectedin for the treatment of advanced uterine or ovarian carcinosarcoma: Results of a phase II multicenter clinical trial (MITO-26)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of trabectedin for the treatment of advanced uterine or ovarian carcinosarcoma: Results of a phase II multicenter clinical trial (MITO-26)

Published:2022-12 Issue:3 Volume:167 Page:436-443
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Lorusso Domenica,Pignata Sandro,Tamberi Stefano,Mangili Giorgia,Bologna Alessandra,Nicoloso Milena Sabrina,Giolitto Serena,Salutari Vanda,Mantero Mara,Pisano Carmela,Bergamini Alice,Musacchio Lucia,Ronzulli Dominique,Raspagliesi Francesco,Scambia Giovanni

Funder

Roche

Meso Scale Diagnostics

AstraZeneca

GlaxoSmithKline

PharmaMar

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference40 articles.

1. Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma;Berton-Rigaud;Int. J. Gynecol. Cancer,2014

2. Uterine carcinosarcoma: a review of the literature;Cantrell;Gynecol. Oncol.,2015

3. Ovarian carcinosarcoma: current developments and future perspectives;Boussios;Crit. Rev. Oncol. Hematol.,2019

4. Pathology of mixed Mullerian tumours;D’Angelo;Best Pract. Res. Clin. Obstet. Gynaecol.,2011

5. Ovarian carcinosarcoma: effects of cytoreductive status and platinum-based chemotherapy on survival;Jernigan;Obstet. Gynecol. Int.,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Metastatic Uterine Carcinosarcoma: A Tailored Approach or One Size Fits All?;Radiation;2024-06-05

2. Top advances of the year: Ovarian cancer;Cancer;2023-12-15

3. Frontiers of Ovarian Carcinosarcoma;Current Treatment Options in Oncology;2023-11-08

4. DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities;Cancers;2023-01-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3